Clinical Trial Consulting
Medical Affairs and Patient Finding in Brazil
We help biopharmaceutical companies identify clinical trial sites, PIs and patients in Brazil.
Clinical Trial Consulting
0M
Population
0
Days Regulatory
Response Time
0+
Years Experience
Market Opportunity
Why Brazil?
The ideal destination for your next clinical trial
Massive Scale
Largest market in Latin America
With 212 million people, Brazil offers unparalleled patient recruitment potential in a single country.
0M
Population
Cost Effective
Competitive trial costs without compromising on quality or regulatory standards. Maximize your R&D budget.
Fast Regulatory
ANVISA provides responses within 90 business days, enabling faster trial initiation than many other markets.
0
BUSINESS DAYS
Genetic Diversity
A unique melting pot of Indigenous, European, African, and Asian heritage for diverse trial populations.
IndigenousEuropeanAfricanAsian
World-Class Sites
Access highly sophisticated, well-equipped clinical research sites with experienced investigators.
Time Zone Aligned
Convenient time zone overlap with the U.S. for seamless real-time collaboration.
About Us
Decades of experience in Brazil and expertise in Gene-Cell therapies
SambaTrials combines deep cell therapy development experience with over 15 years navigating Brazil's regulatory and clinical research landscape. We're your strategic partner for successfully developing and managing relationships with clinical trial sites in the country.
0+Years of Experience
01
Cell Therapy Focus
Specialized knowledge in NK-cell, CAR-T, and next-generation cell therapy clinical development.
02
Brazilian Research Sites
Deep relationships with top-tier clinical research institutions and experienced investigators across Brazil.
03
ANVISA Navigation
Proven track record of successful regulatory submissions and approvals with Brazil's health authority.
04
End-to-End Support
From site selection to patient recruitment to medical affairs — we cover the full trial lifecycle.
What We Offer
Full Medical Affairs Support to Your Trial
Our mission is to help biopharmaceutical companies conduct studies in Brazil while we help Brazilians have early access to cutting edge biotechnology.
01
Site & PI Identification
Strategic identification of optimal clinical trial sites and experienced Principal Investigators across Brazil's top research institutions.
Site SelectionPI MatchingFeasibility
02
Patient Recruitment
Leverage our extensive network to efficiently identify and recruit qualified patients for your trials.
03
PSA & Due Diligence
Comprehensive Pre-Study Assessments and thorough due diligence to ensure site readiness.
Regulatory & ANVISA Support
04Expert navigation of Brazilian regulatory landscape with direct ANVISA meeting coordination and submission support.
ANVISA Meetings
Documentation
Compliance
05
Medical Affairs Strategy
Strategic medical affairs planning and operations tailored for the Brazilian healthcare ecosystem.
06
Clinical Trial Monitoring
Rigorous clinical trial monitoring ensuring quality, compliance, and patient safety throughout.
FAQ
Common Questions
ANVISA typically provides regulatory responses within 90 business days. With proper preparation, you can go from submission to first patient enrolled in 6-9 months.
We specialize in cell therapy trials (NK-cell, CAR-T) but support all phases (I-IV) across therapeutic areas including oncology, autoimmune diseases, and rare diseases.
Yes, Brazilian regulation requires a local sponsor or representative. Samba Trials can serve as your in-country partner, handling regulatory submissions, site management, and local operations.
Clinical trial costs in Brazil are typically 30-50% lower than the US and Europe, while maintaining comparable quality standards and GCP compliance.
ANVISA is Brazil's National Health Surveillance Agency (similar to the FDA). They review clinical trial applications and have streamlined their process to respond within 90 business days for most submissions.
Get Started
Ready to expand your trials to Brazil?
Let's discuss how we can help you navigate the Brazilian clinical trial landscape and find the patients you need.
Access to 800+ research sites across Brazil
ANVISA regulatory response in 90 days
Time zone aligned with US East Coast
Genetically diverse patient population